Its primarily responsible for transporting fatty acids into your cells mitochondria, which are burned for energy
As one of our clinical leads points out , Body Composition measurement tells you what HAS happened
Overall, these results unequivocally show that the decrease in appetite caused by GLP-1 and GIP mimetics is associated with a significant reduction in body weight
Butterfield DA, Poon HF, St Clair D, Keller JN, Pierce WM, Klein JB, et al
67 Controversy Regarding Effects of GLP-1 RAs in Heart Failure: Direct Drug Effects or Due to Weight Loss
The FDA approved the Wegovy pill (oral semaglutide 25 mg, once daily) in late 2025, and it launched in the US in early January 2026